2-DE analysis of breast cancer cell lines 1833 and 4175 with distinct metastatic organ-specific potentials: comparison with parental cell line MDA-MB-231
Jazyk angličtina Země Řecko Médium print
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
R01 CAA082159-03
PHS HHS - United States
PubMed
18425382
Knihovny.cz E-zdroje
- MeSH
- 2D gelová elektroforéza metody MeSH
- hmotnostní spektrometrie metody MeSH
- invazivní růst nádoru MeSH
- kathepsin D biosyntéza MeSH
- kolagenasy biosyntéza MeSH
- koncentrace vodíkových iontů MeSH
- lidé MeSH
- metastázy nádorů MeSH
- nádorové buněčné linie MeSH
- nádory prsu metabolismus patologie MeSH
- peptidy chemie MeSH
- počítačové zpracování obrazu MeSH
- regulace genové exprese u nádorů * MeSH
- stanovení celkové genové exprese MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- Názvy látek
- kathepsin D MeSH
- kolagenasy MeSH
- peptidy MeSH
Human MDA-MB-231 derived breast cancer cell lines 1833 and 4175 have different metastatic potentials in terms of their tissue tropisms and aggressiveness. Cell line 1833 is specifically metastatic to the bone. The highly aggressive cell line 4175 is specific to the lung. We performed 2-DE analysis of the cell lines. We found 16 significantly changed protein spots, 14 protein spots were identified. Expression of cathepsin D, triosephosphate isomerase, phosphoglycerate kinase 1, heme binding protein 1 and annexin 2 could be correlated with the in vitro aggressiveness of the respective cell lines. Interstitial collagenase and dimethylargininase 2 were exclusive to the cell line 1833 and might contribute to its bone specificity. Serpin B9, cathepsin B chain b, galectin 3 and HSP 27 were changed in the lung specific cell line 4175. The possible contribution of identified proteins to differences in metastatic behavior of the cell lines is discussed.